Friday, August 8, 2025

Archegos Collapse: Credit Suisse Takes $4.7 Billion Loss

The implosion of family investment firm hedge fund Archegos Capital Management last month has cost embattled Credit Suisse almost $4.7 billion in losses, and the termination of several of the bank’s top executives.

The Swiss bank was among the hardest hit from the collapse of Bill Hwang’s Archegos, after suffering a significant loss in its unit that services hedge funds. That loss has now been confirmed to be upwards of $4.7 billion, as Credit Suisse announced it will likely report a pretax loss of $959 million in the first quarter of 2021 – a substantial loss for a company that posted net income of $2.9 billion for all of 2020.

In addition, Credit Suisse also revealed that it will terminating its top investment banker Brian Chin, as well as its chief risk officer Lara Warner. The remaining members of the bank’s executive board will not receive bonuses for 2020, meanwhile board chairman Urs Rohner will have to forego $1.6 million in compensation.

In order to increase capital following the serious Archegos financial blow, Credit Suisse also announced that it will discontinue its share buyback program and pay a decreased dividend via a combination of capital and retained earnings. Following the collapse of Hwang’s hedge fund, Credit Suisse shares have fallen by almost a quarter since the beginning of March, but regained some of the losses as of recent.


Information for this briefing was found via Bloomberg. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Nova Scotia Bans Forest Access to Prevent Wildfires

Cardiol Therapeutics Releases Positive Topline Results From Phase II Clinical Trial

Related News

Credit Suisse Tumbles As Largest Investor Refuses To Provide Further Support

Credit Suisse (NYSE: CS) is currently attempting to recover from an over 20% tumble at...

Wednesday, March 15, 2023, 11:17:41 AM

Is Deutsche Bank Next? Shares Plummet As Default Swaps Surge To Record High

Deutsche Bank’s (NYSE: DB) shares have tumbled 8% in pre-market trading to $8.85 after default...

Friday, March 24, 2023, 09:11:33 AM

Prosecutors Seek 21-Year Prison Term for Archegos Founder Hwang

US prosecutors have requested a 21-year prison sentence for Archegos Capital Management founder Bill Hwang,...

Monday, November 18, 2024, 07:07:51 AM

Tensegrity: How the Archegos Tower was Built

Last Week in Bill Hwang saw the head of investment banking and the Chief Risk...

Monday, April 12, 2021, 10:35:00 AM

Credit Suisse Announces New Group CEO After Disappointing Q2 Performance

Credit Suisse Group AG (SWX: CSGN) announced on Wednesday that Thomas Gottstein will be stepping...

Saturday, July 30, 2022, 05:05:00 PM